Last edition
News about "cardio-pulmonary diseases "
Merck to Acquire Verona Pharma for USD 10 Billion to Expand Cardio-Pulmonary Portfolio
Merck, through a subsidiary, will acquire Verona Pharma for USD 107 per American Depository Share (ADS), each of which represents eight shares of Verona Pharma, for a total transaction value of approximately USD 10 billion.
Cardio-pulmonary Diseases | 10/07/2025 | By Dineshwori | 194
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members